These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5191771)

  • 61. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 62. [Experiences with a new antihypertensive agent].
    Thürlimann E
    Ther Ggw; 1968 Jul; 107(7):930-2 passim. PubMed ID: 5719504
    [No Abstract]   [Full Text] [Related]  

  • 63. [New chemotherapy in arterial hypertension].
    Chiti E
    Minerva Med; 1971 Nov; 62(84):4143-8. PubMed ID: 5136617
    [No Abstract]   [Full Text] [Related]  

  • 64. [Long-term hypotensive treatment and clinical course of arterial hypertension].
    Cristodorescu R; Pătraşcu M; Comşulea L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(2):161-72. PubMed ID: 6127773
    [No Abstract]   [Full Text] [Related]  

  • 65. [Behavior of psyche, blood pressure and pulse rate following administration of the antihypertensive agent "Catapresan"].
    Steinbach M
    Med Welt; 1967 Feb; 8():456-8. PubMed ID: 6044570
    [No Abstract]   [Full Text] [Related]  

  • 66. [Antihypertensive drug. Dual action lowers blood pressure more effectively].
    MMW Fortschr Med; 2001 May; 143(18):49. PubMed ID: 11387709
    [No Abstract]   [Full Text] [Related]  

  • 67. [Changes in bronchial patency in arterial hypertension patients following a regimen of hypotensive therapy].
    Almazov VA; Fedoseev GB; Degtiareva ZIa; Katiukhin VN
    Ter Arkh; 1983; 55(3):107-9. PubMed ID: 6134348
    [No Abstract]   [Full Text] [Related]  

  • 68. [Evaluation of the effectiveness of the hypotensive treatment by reaction to physical exertion].
    Zamotaev IP; Andriukova EI; Alekseenko AV
    Sov Med; 1978 Jan; (1):91-5. PubMed ID: 635679
    [No Abstract]   [Full Text] [Related]  

  • 69. [Experiences with a new antihypertensive agent (Tadip)].
    Becker L
    Med Welt; 1968 Jul; 30():1684-5. PubMed ID: 5718817
    [No Abstract]   [Full Text] [Related]  

  • 70. [Treatment of hypertension with clonidine].
    Siitonen L; Koskinen P; Vuorio S; Bäckman H
    Duodecim; 1970; 86(14):818-25. PubMed ID: 5447795
    [No Abstract]   [Full Text] [Related]  

  • 71. [Catapresan (2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride)--a new intraocular pressure lowering agent].
    Hasslinger C
    Klin Monbl Augenheilkd; 1969 Jan; 154(1):95-105. PubMed ID: 5364293
    [No Abstract]   [Full Text] [Related]  

  • 72. [Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
    Krämer D; Krause W; Renner H
    Arzneimittelforschung; 1970 Apr; 20(4):519-21. PubMed ID: 5467817
    [No Abstract]   [Full Text] [Related]  

  • 73. [Antihypertensive drug therapy in relation to lipid disorders].
    Kawecka-Jaszcz K; Stochmal A
    Przegl Lek; 1998; 55(2):85-8. PubMed ID: 9695649
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Hypertension in practice--problem and therapy experiences].
    Matter H
    Wien Med Wochenschr; 1982; 132 Spec No():14-6. PubMed ID: 6123197
    [No Abstract]   [Full Text] [Related]  

  • 75. [The comparative assessment of the efficacy of hypotensive preparations in stage-II hypertension].
    Tiurin VP; Fursov AN; Gospodarenko AL; Liapkova NB; Orlov FA
    Voen Med Zh; 1997 Nov; 318(11):46-7. PubMed ID: 9461836
    [No Abstract]   [Full Text] [Related]  

  • 76. [Experiences with a new antihypertensive drug combination].
    Rácz E
    Orv Hetil; 1966 Oct; 107(41):1940-2. PubMed ID: 5978537
    [No Abstract]   [Full Text] [Related]  

  • 77. [New, in Austria registered specialty drugs. Normoxin (moxonidine)].
    Kögler H; Raneburger J
    Wien Klin Wochenschr; 1993; 105(3):94-6. PubMed ID: 8447129
    [No Abstract]   [Full Text] [Related]  

  • 78. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The use of aminazine as a hypotensive agent in hypertensive crises].
    Krylova NI
    Klin Med (Mosk); 1965 Sep; 43(9):124-5. PubMed ID: 5870036
    [No Abstract]   [Full Text] [Related]  

  • 80. [Obesity and hypertension. A dangerous liaison].
    MMW Fortschr Med; 2002 Oct; 144(43):57. PubMed ID: 12534023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.